A major challenge for chemotherapy has been balancing the ability to damage and kill cancer cells with the collateral damage it can cause to normal, healthy cells.
Aug 25, 2014
4.5 / 5 (4) | 0
Findings of a trial of a drug aimed at treating advanced oesophageal - or gullet - cancer could lead to a new treatment approach for a sub-group of patients with this kind of cancer.
Aug 22, 2014
4 / 5 (2) | 0